Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanne Morrison

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|September 10, 2003
Audit of the care of women requesting induced abortionJoanne Morrison
Seminars in Perinatology|March 19, 2003
Cesarean section on demandJoanne Morrison, I Z MacKenzie
The Journal of the British Menopause Society|April 27, 2004
'Two week wait' standards for suspected gynaecological malignancy. On target, but missing the point?Joanne Morrison, Siobhan Gillespie, I Z MacKenzie
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2007
Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptorJoanne Morrison, Simon S Briggs, Nicola Green, et al.
Human Gene Therapy|March 5, 2009
Cetuximab retargeting of adenovirus via the epidermal growth factor receptor for treatment of intraperitoneal ovarian cancerJoanne Morrison, Simon S Briggs, Nicola K Green, et al.
Virology|November 12, 2013
Adenovirus serotype 11 causes less long-term intraperitoneal inflammation than serotype 5: implications for ovarian cancer therapyClemens Thoma, Veronique Bachy, Patricia Seaton, et al.
The Journal of Gene Medicine|January 25, 2008
Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancerNicola K Green, Joanne Morrison, Sarah Hale, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|September 10, 2003
Audit of the care of women requesting induced abortionJoanne Morrison
Seminars in Perinatology|March 19, 2003
Cesarean section on demandJoanne Morrison, I Z MacKenzie
The Journal of the British Menopause Society|April 27, 2004
'Two week wait' standards for suspected gynaecological malignancy. On target, but missing the point?Joanne Morrison, Siobhan Gillespie, I Z MacKenzie
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2007
Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptorJoanne Morrison, Simon S Briggs, Nicola Green, et al.
Human Gene Therapy|March 5, 2009
Cetuximab retargeting of adenovirus via the epidermal growth factor receptor for treatment of intraperitoneal ovarian cancerJoanne Morrison, Simon S Briggs, Nicola K Green, et al.
Virology|November 12, 2013
Adenovirus serotype 11 causes less long-term intraperitoneal inflammation than serotype 5: implications for ovarian cancer therapyClemens Thoma, Veronique Bachy, Patricia Seaton, et al.
The Journal of Gene Medicine|January 25, 2008
Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancerNicola K Green, Joanne Morrison, Sarah Hale, et al.
Pageof 1